Clinical Trial Update: High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia [NA]

View source ↗

Summary

This ClinicalTrials.gov entry updates a study that uses high-throughput drug sensitivity and genomics to guide individualized treatment for relapsed or refracto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Leukemia

Snippet

Sponsor: University of Washington | Conditions: Plasma Cell Leukemia, Recurrent Multiple Myeloma | NA | Status: ACTIVE_NOT_RECRUITING